Chen Chen focuses her practice on representing public and private biotechnology, pharmaceutical and other life sciences companies in intellectual property and commercial transactions, equity financings, initial public offering, as well as assisting with public company disclosure and corporate governance matters.

Download full bio 


  • Harpoon Therapeutics Announces Worldwide Collaboration with AbbVie 

  • Goldfinch Bio Announces Strategic Collaboration with Gilead 

  • Arcus Biosciences Announces 10-year Partnership with Gilead 

  • Vir Biotechnology - $143 Million IPO 


  • Harvard Law School
    JD, cum laude, 2017

  • Stanford University
    PhD, Chemistry

  • Wesleyan College
    BA, Chemistry
    summa cum laude, 2009

Admissions & Credentials